Sandra Silberman
Chief Tech/Sci/R&D Officer at MOLECULIN BIOTECH, INC.
Net worth: 94 $ as of 31/03/2024
Profile
Sandra Leta Silberman is currently the Chief Medical Officer for Moleculin Biotech, Inc. and CNS Pharmaceuticals, Inc. She previously worked as the Senior Director of Clinical Research at Novartis Corp., Chief Medical Officer at Scorpius Holdings, Inc., and Vice President at Eisai Medical Research, Inc. Silberman holds a doctorate degree from Weill Cornell Medical College and The Johns Hopkins University School of Medicine, and an undergraduate degree from Zanvyl Krieger School of Arts & Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/07/2023 | 261 ( 0.00% ) | 94 $ | 31/03/2024 |
Sandra Silberman active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 08/11/2017 |
| CNS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Former positions of Sandra Silberman
| Companies | Position | End |
|---|---|---|
| Eisai Medical Research, Inc. | Corporate Officer/Principal | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Sandra Silberman
| Weill Cornell Medical College | Doctorate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Zanvyl Krieger School of Arts & Sciences | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Eisai Medical Research, Inc. |
- Stock Market
- Insiders
- Sandra Silberman
